The latest research result of Prof. Li Zunling’ s team from the Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, titled Targeting the Immunoglobulin IGSF9 Enhances Anti-tumor T Cell Activity and Sensitivity to Anti-PD-1 Immunotherapy, has been published in Cancer Research, a top medical journal.
The study theoretically discovers a new tumor-specific immune checkpoint molecule, elucidates its expression mode and mechanism of action, and develops a corresponding therapeutic antibody, which is expected to bring new therapeutic approaches for tumor patients.
The first author of this paper is Liu Yifan, a graduate student of Class of 2022, who is now a doctoral student of Academician He Fuchu at the Academy of Military Medical Sciences.
Original Link: https://aacrjournals.org/cancerres/article-abstract/doi/10.1158/0008-5472.CAN-22-3115/728067/Targeting-the-immunoglobulin-IGSF9-enhances-anti?redirectedFrom=fulltext
BY: Wang Jianqiang
SOURCE: News Center
